Low Dose Epcoritamab Plus GemOx in R/R DLBCL

Clinical trial NCT07451652 · RECRUITING

Trial details

NCT number: NCT07451652
Sponsor: Hospital Universitario Dr. Jose E. Gonzalez
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed/Refractory Diffuse Large B Cell Lymphoma

Start date: 2026-03-17
Primary completion: 2027-09-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.